Robert Stowe England • July 25, 2014
Diversification and a desire to move into other equity classes sparked a turnaround in international equities during the first quarter.
Ben Baris • July 24, 2014
Glenview’s Larry Robbins and Omega Advisors’ Leon Cooperman both touted life sciences stalwart Thermo Fisher Scientific at the recent Delivering Alpha conference.
Michael Hood • July 24, 2014
Limited policy easing in emerging economies leaves growth in those markets more dependent on developed markets’ economic cycles.
Aaron Timms • July 24, 2014
Stan Druckenmiller believes inversions present an opportunity to pursue broader reform of the U.S. tax system, tax hikes included.
Martin Hegarty • July 23, 2014
Narrowing unemployment and changes to housing costs stand to push up inflation in the near term.
Mark Pey • July 23, 2014
Bitcoin goes beyond being a cross-border digital currency whose value is determined by the free market. It’s also an exercise in rethinking money itself.
Tom Buerkle • July 23, 2014
The Irish entrepreneur is spending heavily to develop his mobile network in the Caribbean and Pacific — and to give back to the community.
Imogen Rose-Smith • July 22, 2014
Pensions are a key issue in Rhode Island’s governor’s race. Providence Mayor Angel Taveras praises his city’s reform plan, but deficits remain.
Dan Weil • July 22, 2014
The veteran credit analyst sees parallels between today’s market and that of the early 1980s, when he first made a name for himself in high-yield-debt research.
Daniel Nadler • July 22, 2014
Crowdfunding project OpenWorm could not only dramatically reduce the time frame for developing drugs and bringing them to market, it could also change the way scientific research is done.
© 2014 Institutional Investor LLC. All material subject to strictly enforced copyright laws.
Please read our
Term and Conditions and